血清IL-41的增加与慢性阻塞性肺病的急性恶化有关
Tiantian Cen1, Minxuan Huang1, Mingcai Li1
1Department of Respiratory and Critical Care Medicine, Key Laboratory of Respiratory Disease of Ningbo, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang 315010, P.R. China.
在经历慢性阻塞性肺病 (AECOPD) 急性恶化患者中,白血素-41 (IL-41) 水平升高. 较高的IL-41与恶化的严重程度相关,有助于诊断AECOPD,特别是其他炎症标志物.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 生物化学 生物化学
背景情况:
- 介素-41 (IL-41) 是一种免疫调节性细胞因子,涉及炎症和代谢疾病.
- 它在慢性阻塞性肺病 (COPD) 发病过程中的特定作用仍然在很大程度上未被探索.
研究的目的:
- 调查介素-41 (IL-41) 表达水平与慢性阻塞性肺病 (AECOPD) 的急性恶化之间的相关性.
- 评估IL-41在区分AECOPD与稳定的COPD和健康对照中的诊断价值.
主要方法:
- 酶相关免疫吸收试验 (ELISA) 用于测量107名COPD患者和56名健康对照者的IL-41,IL-6和矩阵金属蛋白酶-2 (MMP-2) 血清水平.
- 还评估了血清粉样蛋白A (SAA) 和C反应蛋白 (CRP) 的水平.
- 采用接收器操作特征 (ROC) 曲线分析来评估诊断准确性.
主要成果:
- 与稳定的COPD (SCOPD) 和对照组 (P<0.0001) 相比,AECOPD组的血清IL-41水平显著更高.
- 升高的IL-41与吸烟指数,恶化频率,严重程度和COPD评估测试成绩有正相关性.
- 特别是IL-41与其他炎症标志物相结合,证明了AECOPD的显著诊断价值 (AUC=0.925).
结论:
- 血清IL-41水平升高与COPD急性恶化 (AECOPD) 有着强烈的关联.
- IL-41可以作为监测和评估COPD恶化的有价值的生物标志物.
- 结合IL-41和其他炎症因子的分析,提高了AECOPD的诊断特异性.
更多相关视频
11:07Inducing Acute Lung Injury in Mice by Direct Intratracheal Lipopolysaccharide Instillation
Published on: July 6, 2019
06:29Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo
Published on: May 5, 2023
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Pneumonia II: Pathophysiology
